Target Name: IQCC
NCBI ID: G55721
Review Report on IQCC Target / Biomarker Content of Review Report on IQCC Target / Biomarker
IQCC
Other Name(s): IQCC variant 2 | IQ domain-containing protein C | IQCC_HUMAN | IQ motif containing C | FLJ10547 | IQ motif containing C, transcript variant 2 | OTTHUMP00000006377 | MGC120341 | RP4-622L5.6 | IQ domain-containing protein C (isoform 2)

IQCC: A Key Regulator of Cellular Signaling and Division

IQCC (IQCC variant 2) is a protein that is expressed in various tissues and cells of the human body. It is a member of the superfamily of Integron proteins, which are a type of transmembrane protein that play a structural role in many different cell processes. IQCC is also known as Integron- associated protein CC (IAPC) and it is a key regulator of the Integron complex. The Integron complex is a protein complex that plays a role in the process of cell division, and it is involved in the formation of the nuclear envelope and the cytoskeleton.

IQCC is a 21-kDa protein that is expressed in various tissues and cells of the human body. It is highly conserved, with a calculated pI of 4.8 and a predicted monomeric molecular weight of 13.9 kDa. IQCC is a member of the superfamily of Integron proteins, which are a type of transmembrane protein that play a structural role in many different cell processes. These proteins are involved in the regulation of cell division, cell signaling, and tissue development.

One of the key functions of IQCC is its role as a regulator of the Integron complex. The Integron complex is a protein complex that plays a role in the process of cell division, and it is involved in the formation of the nuclear envelope and the cytoskeleton. IQCC is one of the key proteins that regulates the activity of the Integron complex. It is involved in the regulation of the assembly and disassembly of the Integron complex, and it is thought to play a role in the regulation of cell division.

IQCC is also involved in the regulation of gene expression. It is a negative regulator of the nuclear factor of activating T cells (NFAT), which is a transcription factor that regulates the expression of many different genes. IQCC is thought to work by binding to the nuclear factor of activating T cells (NFAT), preventing it from activating target genes. This is thought to play a role in the regulation of cell fate, and it is involved in the development and maintenance of tissues such as the brain, heart, and gastrointestinal tract.

In addition to its role as a regulator of the Integron complex and gene expression, IQCC is also involved in the regulation of cellular signaling. It is a component of several different signaling pathways, including the TGF-β pathway and the Wnt pathway. These signaling pathways are involved in the regulation of cell growth, differentiation, and survival.

IQCC is also a potential drug target. Its role as a regulator of the Integron complex and gene expression makes it a potential target for small molecules that can modulate these processes. Additionally, its role as a negative regulator of the nuclear factor of activating T cells (NFAT) makes it a potential target for drugs that can inhibit the activity of this transcription factor.

IQCC is also a potential biomarker. Its role as a regulator of the Integron complex and gene expression makes it a potential target for diagnostic tests that can measure these processes. Additionally, its role as a negative regulator of the nuclear factor of activating T cells (NFAT) makes it a potential target for diagnostic tests that can measure the activity of this transcription factor.

Overall, IQCC is a highly conserved protein that plays a key role in the regulation of cell division, gene expression, and cellular signaling. Its potential as a drug target and biomarker makes it a promising target for the development of new therapies for a variety of diseases. Further research is needed to fully understand its functions and to develop effective treatments.

Protein Name: IQ Motif Containing C

The "IQCC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IQCC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IQCD | IQCE | IQCF1 | IQCF2 | IQCF3 | IQCF5-AS1 | IQCF6 | IQCG | IQCH | IQCH-AS1 | IQCJ | IQCJ-SCHIP1 | IQCK | IQCM | IQCN | IQGAP1 | IQGAP2 | IQGAP3 | IQSEC1 | IQSEC2 | IQSEC3 | IQSEC3P3 | IQUB | IRAG1 | IRAG1-AS1 | IRAG2 | IRAK1 | IRAK1BP1 | IRAK2 | IRAK3 | IRAK4 | IREB2 | IRF1 | IRF1-AS1 | IRF2 | IRF2BP1 | IRF2BP2 | IRF2BPL | IRF3 | IRF4 | IRF5 | IRF6 | IRF7 | IRF8 | IRF9 | IRGC | IRGM | IRGQ | IRS1 | IRS2 | IRS4 | IRX1 | IRX2 | IRX2-DT | IRX3 | IRX4 | IRX5 | IRX6 | ISCA1 | ISCA1P1 | ISCA2 | ISCU | ISG15 | ISG20 | ISG20L2 | ISL1 | ISL1-DT | ISL2 | ISLR | ISLR2 | ISM1 | ISM2 | ISOC1 | ISOC2 | Isocitrate dehydrogenase 3 (NAD+) | Isocitrate dehydrogenases | Isoleucyl-tRNA synthetase | IST1 | ISWI Chromatin Remodeling Complex | ISX | ISY1 | ISY1-RAB43 | ISYNA1 | ITCH | ITFG1 | ITFG2 | ITFG2-AS1 | ITGA1 | ITGA10 | ITGA11 | ITGA2 | ITGA2B | ITGA3 | ITGA4 | ITGA5 | ITGA6 | ITGA6-AS1 | ITGA7 | ITGA8 | ITGA9